MissionIR Articles
-
MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Bringing Precision Medicine Tools to Physicians
Predictive Oncology (NASDAQ: POAI) is assisting clinicians and researchers in improving outcomes for cancer patients via its AI-driven, tumor-profiling platform. A recent article discussing the company reads, “POAI’s technology combines its database of evidence documenting…
-
MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Advances Within Competitive Canadian Cannabis Space
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified-organic cannabis, is on a mission to meet the growing demand for organic cannabis in Canada.…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Patented PCT Platform Highlighted in 10 Separate Presentations at International Human Proteome Organization World Congress
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its patented pressure cycling technology (“PCT”)…
-
ChineseInvestors.com Inc. (CIIX) MicroCap Presentation Well Received, CBD Future Bright
CIIX CEO Warren Wang reported that MicroCap Conference attendees showed interest in the company’s presentation In a MoneyTV interview, Wang expressed optimism about the long-range sales of CBD; CIIX will focus on the CBD cosmetics…
-
MissionIRNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Chief Marketing Officer Recognized on Forbes CMO Next List
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced that Jann Parish, Chief Marketing Officer, has been named to the Forbes CMO Next list, a list comprised of 50 individuals considered to…
-
Pressure BioSciences Inc.’s (PBIO) Proprietary Technology Platform Identified as Key Cancer Biomarker Research Element
Independent research carried out by Chinese and Australian scientists shows that the Pressure BioSciences Pressure Cycling Technology (PCT) platform is excellent for the processing of preserved (formalin-fixed paraffin-embedded, or FFPE) and fresh frozen biopsy tissues,…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Powdered Formulation of CBD-Rich Hemp Oil Now Available to US Consumers
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, recently launched its ChrgD+ product, a water-soluble, multispectrum hemp oil in a powdered format powered by the company’s proprietary DehydraTECH(TM) technology for rapid…
-
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Confirms Robust Demand for Premium Organic Cannabis
The Green Organic Dutchman produces high-quality, organic cannabis for the medicinal and recreational adult use markets from purpose-built, state-of-the-art facilities The company has confirmed higher demand for premium organic cannabis TGOD has also announced positive…
-
Earth Science Tech Inc. (ETST) Expands in the CBD Space, Establishes New Sales Unit
Earth Science Tech has launched a new sales division focused on CBD, led by Industry-veteran Erika Franck ETST’s portfolio is positioned in the dually lucrative biotechnology and cannabis/cannabidiol industries Biotechnology currently represents the largest segment…
-
MissionIRNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Highlighted in Editorial on Potential Breast Cancer Treatments
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced its placement in an editorial published by NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company for private and public entities. The publication, titled “Gene…
-
MissionIRNewsBreaks – SRAX, Inc. (NASDAQ: SRAX) to Present at the 5th Annual B. Riley Consumer & Media Conference in NYC
Digital marketing and consumer data management technology company SRAX (NASDAQ: SRAX) today announced that it is scheduled to present at the 5th Annual B. Riley Consumer & Media Conference to be held at the Sofitel…
-
MissionIRNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) to Report Results, Host Earnings Conference Call for Q4 and Fiscal Year 2019
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Tuesday announced that it will report results for the fourth quarter and fiscal year 2019 ending June 30, 2019, on Wednesday, October 23, 2019,…
-
MissionIRNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Closes $8.3M Public Offering; Launches HEMP FX Brand in Japan
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, on Tuesday announced the closing of its underwritten public offering of 333,500 shares of its 9.75% Series D Cumulative Redeemable…
-
Pressure BioSciences Inc. (PBIO) Issues Update on Guidance for Revenue Growth and Success of Revolutionary CBD Oil Processing System
The company believes that its total revenue will more than double in 2020, led by commercialization of its revolutionary CBD oil nanoemulsification system PBIO’s BaroShear K45, based on the company’s proprietary Ultra Shear Technology (UST)…
-
Earth Science Tech Inc. (ETST) Appoints Experienced Head of New CBD Sales Division, Files Securities Registration Statement
ETST is focused on its developing role as an international leader in the CBD space The company recently filed a securities registration statement with the SEC ETST recently named a pharmaceutical and orthopedic expert as…
-
MissionIRNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) CEO Discusses Company Achievements in Interview; Director of Neuroscience to Present at World Immunotherapy Congress
RJ Tesi, M.D., co-founder and CEO of clinical-stage immunology company INmune Bio (NASDAQ: INMB), was recently featured in an interview with multimedia financial reporter Jason Lin. Among other highlights, Dr. Tesi discusses recent company accomplishments…
-
MissionIRNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) to Present XPro1595 for Treating Neuroinflammation in Alzheimer’s Disease at 2019 AAIC Satellite Symposium
INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced its plans to present at the upcoming Alzheimer’s Association International…
-
Is SRAX Inc. (NASDAQ: SRAX) and its BIGtoken Platform Building One of the Most Valuable Opted-In Data Sets in the World?
SRAX sold its pharmaceutical arm, SRAXmd, and it continues to invest in its flourishing BIGtoken platform Major brands Kraft and Sun-Maid launched programs within the BIGtoken platform SRAX continues toward its goal of developing the…
-
Big Brands Embrace SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Platform with Integrated Big Rewards™ Programs
Major CPG brands Kraft and Sun-Maid partner with SRAX through BIGtoken platform BIGtoken continues global expansion, entering the EU market SRAX is building what it hails as the most valuable opted-in data set in the…
-
MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Transforming Cancer-Treatment Outcomes via Proprietary Database
Predictive Oncology (NASDAQ: POAI) is taking a unique approach to cancer treatment by utilizing its proprietary database of cancer cases using the proven power of artificial intelligence (“AI”). A recent article discussing the company reads,…
Search Articles
Latest Articles
- A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Advancing Retail Innovation Through AI-Powered Smart-Cart Technology
- Forward Industries Inc. (NASDAQ: FWDI) Positive Update for Shareholders After Debuting the Company’s Solana Treasury Strategy
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Secures Funding to Strengthen North American Supply Chain
- MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial on Rare Disease Therapies
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast